| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hypertriglyceridemia | |||||
| 2 | More general conditions related to this trial | ||||
| Dyslipidemias | |||||
| Hyperlipidemias | |||||
| Lipid Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Diazoxide choline | |||||
| Placebo | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Choline | |||||
| Diazoxide | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antihypertensive Agents | |||||
| Antilipemic Agents | |||||
| Antimetabolites | |||||
| Cardiovascular Agents | |||||
| Central Nervous System Agents | |||||
| Gastrointestinal Agents | |||||
| Lipotropic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Nootropic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| Essentialis, Inc. | |||||
| Medpace, Inc. | |||||
|
